Skip to main content
. 2022 Aug 8;24(12):2319–2330. doi: 10.1111/dom.14816

FIGURE 1.

FIGURE 1

Changes in myocardial glucose metabolic rate after exposure to empagliflozin or glimepiride for 26 weeks. Data are means ± SD, and analysed using ANCOVA adjusting for baseline values. The mean change in myocardial glucose metabolic rate is presented as mean (95% CI), and the adjusted difference between the groups is shown with 95% CI